Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Monazzah Akbar Sarwar
Observed names:
Monazzah A. Sarwar,
Monazzah Sarwar,
Sarwar, Monazzah,
Sarwar, Monazzah Akbar
Institution:
University of Illinois Chicago
Observed institutions:
University of Illinois Chicago,
Center for Clinical and Translational Science,
Tecnológico de Monterrey
ORCID:
0000-0001-6642-3418
Observed ORCID:
0000-0001-6642-3418
OpenAlex ID:
A5049831534
Pathological consequences of anti-citrullinated protein antibodies in tear fluid and therapeutic potential of pooled human immune globulin-eye drops in dry eye disease
2019
·
Jieun Kwon
, Bayasgalan Surenkhuu
, et al.
·
The Ocular Surface
·
45
Combinatorial therapy with immunosuppressive, immunomodulatory and tear substitute eyedrops (“Triple Play”) in Recalcitrant Immunological Ocular Surface Diseases
2021
·
Eitan A. Katz
, Sarah Sunshine
, et al.
·
The Ocular Surface
·
17
Ocular graft-versus-host disease: Experience, incidence, and treatment outcomes at a university-based tertiary care ophthalmology center
2025
·
Zeenal G. Dabre
, Tanya Sheth
, et al.
·
The Ocular Surface
·
9
Novel Management of Ocular Surface Inflammation in Patients With Ocular Graft-Versus-Host Disease in the Setting of Cataract Surgery
2024
·
Daniela Roca
, Sandeep Jain
, et al.
·
Eye & Contact Lens Science & Clinical Practice
·
9
Corneal Fluorescein Staining in FDA-Reviewed Dry Eye Registrational Clinical Trials: Evidence of Limited Endpoint Responsiveness
2026
·
Zeenal Dabre
, Christine Mun
, et al.
·
Ophthalmic Research
·
7
PDF
Recombinant Deoxyribonuclease I Eye Drops for Ocular Graft Versus Host Disease: Results of a Randomized Clinical Trial
2024
·
Christine S. Mun
, Bayasgalan Surenkhuu
, et al.
·
Eye & Contact Lens Science & Clinical Practice
·
5
Safety and tolerability of topical mesenchymal stromal cell secretome in persistent corneal epithelial disease—a phase 1b clinical trial
2026
·
Farshad Abedi
, Jeonghyun (Esther) Kwon
, et al.
·
Cytotherapy
·
2
A post-HSCT ocular surface “Window of Opportunity for Pre-emptive ocular treatment (WinOP)” shows early inflammatory activation and an oGVHD-like molecular subset
2026
·
Zeenal Dabre
, Christine Mun
, et al.
·
The Ocular Surface
Show more works
View as search
Works count:
10
Citation count:
94
H-index:
5
I10-index:
2
Year
Topic
Type